Drugmakers ' Shares Stabilize After Zantac Litigation Slump Drugmakers ' Shares Stabilize After Zantac Litigation Slump

Shares in GSK, Sanofi, Haleon and Pfizer began to recover on Friday after the companies said that nothing material had changed regarding US litigation focused on heartburn drug Zantac.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news